Skip to main content
Erschienen in: Cancer Causes & Control 8/2013

01.08.2013 | Original paper

Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study

verfasst von: Kathryn M. Wilson, Katarina Bälter, Elisabeth Möller, Hans-Olov Adami, Ove Andrén, Swen-Olof Andersson, Henrik Grönberg, Lorelei A. Mucci

Erschienen in: Cancer Causes & Control | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Coffee intake has recently been associated with significantly lower risk of lethal and advanced prostate cancer in a US population.

Methods

We studied the association between coffee and prostate cancer risk in the population-based case–control study Cancer of the Prostate in Sweden. Dietary data were available for 1,499 cases and 1,112 controls. We calculated odds ratios (ORs) for the risk of prostate cancer in high versus low categories of coffee intake using logistic regression. We studied overall prostate cancer risk as well as risk of fatal, advanced, localized, high-grade, grade 7, and low-grade disease.

Results

Mean coffee intake was 3.1 cups per day among both cases and controls. Coffee intake was not associated with overall prostate cancer risk. Risk of fatal prostate cancer was inversely, but not statistically significantly, associated with coffee intake, with an odds ratio of 0.64 [95 % confidence interval (CI) 0.34–1.19, p value for linear trend = 0.81] for men consuming greater than 5 cups per day compared to men drinking less than 1 cup per day. The highest intake of coffee was associated non-significantly with lower risk of advanced disease (OR = 0.73, 95 % CI 0.41–1.30, p trend = 0.98) and associated significantly with lower risk of high-grade cancer (Gleason 8–10; OR = 0.50, 95 % CI 0.26–0.98, p trend = 0.13). Risk of localized, grade 7, and low-grade cancers was not associated with coffee intake.

Conclusions

This study provides some support of an inverse association between coffee and lethal and high-grade prostate cancer.
Literatur
1.
Zurück zum Zitat Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, Stampfer MJ, Giovannucci E, Mucci LA (2011) Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 103(11):876–884PubMedCrossRef Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, Stampfer MJ, Giovannucci E, Mucci LA (2011) Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 103(11):876–884PubMedCrossRef
2.
Zurück zum Zitat Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, Jacobs DR Jr et al (2004) Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134(3):562–567PubMed Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, Jacobs DR Jr et al (2004) Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134(3):562–567PubMed
3.
Zurück zum Zitat Pulido R, Hernandez-Garcia M, Saura-Calixto F (2003) Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet. Eur J Clin Nutr 57(10):1275–1282PubMedCrossRef Pulido R, Hernandez-Garcia M, Saura-Calixto F (2003) Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet. Eur J Clin Nutr 57(10):1275–1282PubMedCrossRef
4.
Zurück zum Zitat Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M et al (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 91(4):950–957PubMedCrossRef Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M et al (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 91(4):950–957PubMedCrossRef
5.
Zurück zum Zitat Tunnicliffe JM, Shearer J (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 33(6):1290–1300PubMedCrossRef Tunnicliffe JM, Shearer J (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 33(6):1290–1300PubMedCrossRef
6.
Zurück zum Zitat Svartberg J, Midtby M, Bonaa KH, Sundsfjord J, Joakimsen RM, Jorde R (2003) The associations of age, lifestyle factors and chronic disease with testosterone in men: The Tromso study. Eur J Endocrinol 149(2):145–152PubMedCrossRef Svartberg J, Midtby M, Bonaa KH, Sundsfjord J, Joakimsen RM, Jorde R (2003) The associations of age, lifestyle factors and chronic disease with testosterone in men: The Tromso study. Eur J Endocrinol 149(2):145–152PubMedCrossRef
7.
Zurück zum Zitat Hsieh CC, Signorello LB, Lipworth L, Lagiou P, Mantzoros CS, Trichopoulos D (1998) Predictors of sex hormone levels among the elderly: a study in Greece. J Clin Epidemiol 51(10):837–841PubMedCrossRef Hsieh CC, Signorello LB, Lipworth L, Lagiou P, Mantzoros CS, Trichopoulos D (1998) Predictors of sex hormone levels among the elderly: a study in Greece. J Clin Epidemiol 51(10):837–841PubMedCrossRef
8.
Zurück zum Zitat Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL et al (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9(11):1039–1047PubMedCrossRef Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL et al (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9(11):1039–1047PubMedCrossRef
9.
Zurück zum Zitat Hammarsten J, Hogstedt B (2005) Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41(18):2887–2895PubMedCrossRef Hammarsten J, Hogstedt B (2005) Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41(18):2887–2895PubMedCrossRef
10.
Zurück zum Zitat Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG (2002) Increased serum insulin associated with increased risk of prostate cancer recurrence. Prostate 50(1):1–3PubMedCrossRef Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG (2002) Increased serum insulin associated with increased risk of prostate cancer recurrence. Prostate 50(1):1–3PubMedCrossRef
11.
Zurück zum Zitat De Marzo AM, Nakai Y, Nelson WG (2007) Inflammation, atrophy, and prostate carcinogenesis. Urol Oncol 25(5):398–400PubMedCrossRef De Marzo AM, Nakai Y, Nelson WG (2007) Inflammation, atrophy, and prostate carcinogenesis. Urol Oncol 25(5):398–400PubMedCrossRef
12.
Zurück zum Zitat Bardia A, Platz EA, Yegnasubramanian S, De Marzo AM, Nelson WG (2009) Anti-inflammatory drugs, antioxidants, and prostate cancer prevention. Curr Opin Pharmacol 9(4):419–426PubMedCrossRef Bardia A, Platz EA, Yegnasubramanian S, De Marzo AM, Nelson WG (2009) Anti-inflammatory drugs, antioxidants, and prostate cancer prevention. Curr Opin Pharmacol 9(4):419–426PubMedCrossRef
13.
Zurück zum Zitat Schroder FH, van Weerden WM (2009) Prostate cancer—chemoprevention. Eur J Cancer 45(Suppl 1):355–359PubMedCrossRef Schroder FH, van Weerden WM (2009) Prostate cancer—chemoprevention. Eur J Cancer 45(Suppl 1):355–359PubMedCrossRef
14.
Zurück zum Zitat Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, Appleby P, Key TJ (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100(3):170–183PubMedCrossRef Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, Appleby P, Key TJ (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100(3):170–183PubMedCrossRef
15.
Zurück zum Zitat Platz EA, Giovannucci E (2004) The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92(4):237–253PubMedCrossRef Platz EA, Giovannucci E (2004) The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92(4):237–253PubMedCrossRef
16.
Zurück zum Zitat Nomura A, Heilbrun LK, Stemmermann GN (1986) Prospective study of coffee consumption and the risk of cancer. J Natl Cancer Inst 76(4):587–590PubMed Nomura A, Heilbrun LK, Stemmermann GN (1986) Prospective study of coffee consumption and the risk of cancer. J Natl Cancer Inst 76(4):587–590PubMed
17.
Zurück zum Zitat Severson RK, Nomura AM, Grove JS, Stemmermann GN (1989) A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49(7):1857–1860PubMed Severson RK, Nomura AM, Grove JS, Stemmermann GN (1989) A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49(7):1857–1860PubMed
18.
Zurück zum Zitat Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T (1994) Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5(3):276–282PubMedCrossRef Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T (1994) Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5(3):276–282PubMedCrossRef
19.
Zurück zum Zitat Jacobsen BK, Bjelke E, Kvale G, Heuch I (1986) Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76(5):823–831PubMed Jacobsen BK, Bjelke E, Kvale G, Heuch I (1986) Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76(5):823–831PubMed
20.
Zurück zum Zitat Slattery ML, West DW (1993) Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States). Cancer Causes Control 4(6):559–563PubMedCrossRef Slattery ML, West DW (1993) Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States). Cancer Causes Control 4(6):559–563PubMedCrossRef
21.
Zurück zum Zitat Jain MG, Hislop GT, Howe GR, Burch JD, Ghadirian P (1998) Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer 78(6):707–711PubMedCrossRef Jain MG, Hislop GT, Howe GR, Burch JD, Ghadirian P (1998) Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer 78(6):707–711PubMedCrossRef
22.
Zurück zum Zitat Villeneuve PJ, Johnson KC, Kreiger N, Mao Y (1999) Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 10(5):355–367PubMedCrossRef Villeneuve PJ, Johnson KC, Kreiger N, Mao Y (1999) Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 10(5):355–367PubMedCrossRef
23.
Zurück zum Zitat Sharpe CR, Siemiatycki J (2002) Consumption of non-alcoholic beverages and prostate cancer risk. Eur J Cancer Prev 11(5):497–501PubMedCrossRef Sharpe CR, Siemiatycki J (2002) Consumption of non-alcoholic beverages and prostate cancer risk. Eur J Cancer Prev 11(5):497–501PubMedCrossRef
24.
Zurück zum Zitat Hsieh CC, Thanos A, Mitropoulos D, Deliveliotis C, Mantzoros CS, Trichopoulos D (1999) Risk factors for prostate cancer: a case–control study in Greece. Int J Cancer 80(5):699–703PubMedCrossRef Hsieh CC, Thanos A, Mitropoulos D, Deliveliotis C, Mantzoros CS, Trichopoulos D (1999) Risk factors for prostate cancer: a case–control study in Greece. Int J Cancer 80(5):699–703PubMedCrossRef
25.
Zurück zum Zitat Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS (2005) Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin. Cancer 103(1):76–84PubMedCrossRef Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS (2005) Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin. Cancer 103(1):76–84PubMedCrossRef
26.
Zurück zum Zitat Gallus S, Foschi R, Talamini R, Altieri A, Negri E, Franceschi S et al (2007) Risk factors for prostate cancer in men aged less than 60 years: a case–control study from Italy. Urology 70(6):1121–1126PubMedCrossRef Gallus S, Foschi R, Talamini R, Altieri A, Negri E, Franceschi S et al (2007) Risk factors for prostate cancer in men aged less than 60 years: a case–control study from Italy. Urology 70(6):1121–1126PubMedCrossRef
27.
Zurück zum Zitat Ellison LF (2000) Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur J Cancer Prev 9(2):125–130PubMedCrossRef Ellison LF (2000) Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur J Cancer Prev 9(2):125–130PubMedCrossRef
28.
Zurück zum Zitat Gronberg H, Damber L, Damber JE (1996) Total food consumption and body mass index in relation to prostate cancer risk: a case–control study in Sweden with prospectively collected exposure data. J Urol 155(3):969–974PubMedCrossRef Gronberg H, Damber L, Damber JE (1996) Total food consumption and body mass index in relation to prostate cancer risk: a case–control study in Sweden with prospectively collected exposure data. J Urol 155(3):969–974PubMedCrossRef
29.
Zurück zum Zitat Fincham SM, Hill GB, Hanson J, Wijayasinghe C (1990) Epidemiology of prostatic cancer: a case–control study. Prostate 17(3):189–206PubMedCrossRef Fincham SM, Hill GB, Hanson J, Wijayasinghe C (1990) Epidemiology of prostatic cancer: a case–control study. Prostate 17(3):189–206PubMedCrossRef
30.
Zurück zum Zitat Talamini R, Franceschi S, La Vecchia C, Serraino D, Barra S, Negri E (1992) Diet and prostatic cancer: a case–control study in northern Italy. Nutr Cancer 18(3):277–286PubMedCrossRef Talamini R, Franceschi S, La Vecchia C, Serraino D, Barra S, Negri E (1992) Diet and prostatic cancer: a case–control study in northern Italy. Nutr Cancer 18(3):277–286PubMedCrossRef
31.
Zurück zum Zitat Park CH, Myung SK, Kim TY, Seo HG, Jeon YJ, Kim Y (2010) Coffee consumption and risk of prostate cancer: a meta-analysis of epidemiological studies. BJU Int 106(6):762–769PubMedCrossRef Park CH, Myung SK, Kim TY, Seo HG, Jeon YJ, Kim Y (2010) Coffee consumption and risk of prostate cancer: a meta-analysis of epidemiological studies. BJU Int 106(6):762–769PubMedCrossRef
32.
Zurück zum Zitat Yu X, Bao Z, Zou J, Dong J (2011) Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11(1):96–106PubMedCrossRef Yu X, Bao Z, Zou J, Dong J (2011) Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11(1):96–106PubMedCrossRef
33.
Zurück zum Zitat Phillips RL, Snowdon DA (1983) Association of meat and coffee use with cancers of the large bowel, breast, and prostate among Seventh-Day Adventists: preliminary results. Cancer Res 43(5 Suppl):2403s–2408sPubMed Phillips RL, Snowdon DA (1983) Association of meat and coffee use with cancers of the large bowel, breast, and prostate among Seventh-Day Adventists: preliminary results. Cancer Res 43(5 Suppl):2403s–2408sPubMed
34.
Zurück zum Zitat Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, Wacholder S et al (1990) Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 50(21):6836–6840PubMed Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, Wacholder S et al (1990) Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 50(21):6836–6840PubMed
35.
Zurück zum Zitat Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS (2012) Coffee consumption and prostate cancer risk: further evidence for inverse relationship. Nutr J 11(1):42–48PubMedCrossRef Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS (2012) Coffee consumption and prostate cancer risk: further evidence for inverse relationship. Nutr J 11(1):42–48PubMedCrossRef
36.
Zurück zum Zitat Arab L, Su LJ, Steck SE, Ang A, Fontham ETH, Bensen JT, Mohler JL (2012) Coffee consumption and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study. Nutr Cancer 64(5):637–642PubMedCrossRef Arab L, Su LJ, Steck SE, Ang A, Fontham ETH, Bensen JT, Mohler JL (2012) Coffee consumption and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study. Nutr Cancer 64(5):637–642PubMedCrossRef
37.
Zurück zum Zitat Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO et al (2006) Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: The Cancer Prostate Sweden Study (Sweden). Cancer Causes Control 17(2):169–180PubMedCrossRef Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO et al (2006) Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: The Cancer Prostate Sweden Study (Sweden). Cancer Causes Control 17(2):169–180PubMedCrossRef
38.
Zurück zum Zitat Khani BR, Ye W, Terry P, Wolk A (2004) Reproducibility and validity of major dietary patterns among Swedish women assessed with a food-frequency questionnaire. J Nutr 134(6):1541–1545PubMed Khani BR, Ye W, Terry P, Wolk A (2004) Reproducibility and validity of major dietary patterns among Swedish women assessed with a food-frequency questionnaire. J Nutr 134(6):1541–1545PubMed
39.
Zurück zum Zitat Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS et al (2009) Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol 27(21):3459–3464PubMedCrossRef Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS et al (2009) Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol 27(21):3459–3464PubMedCrossRef
Metadaten
Titel
Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study
verfasst von
Kathryn M. Wilson
Katarina Bälter
Elisabeth Möller
Hans-Olov Adami
Ove Andrén
Swen-Olof Andersson
Henrik Grönberg
Lorelei A. Mucci
Publikationsdatum
01.08.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 8/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0234-9

Weitere Artikel der Ausgabe 8/2013

Cancer Causes & Control 8/2013 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.